According to a new report, published by KBV research, The Global Topical Wound Agents Market size is expected to reach $2.5 billion by 2030, rising at a market growth of 8.4% CAGR during the forecast period.
The Clinics segment is experiencing a CAGR of 9% during (2023 - 2030). Increasing surgical procedures and the proliferation of clinics are significant contributors to the segment's expansion over the forecast period. Increasing incidences of surgical incisions are also significant contributors to the robust segment demand. The increasing importance of postoperative wound care has led to a surge in the need for topical wound agents from medical facilities and patients.
The Chronic Wounds segment is leading the Global Topical Wound Agents Market by Application in 2022; thereby, achieving a market value of $1,967.1 million by 2030. Chronic diseases such as obesity, diabetes, and cardiovascular disorders are factors that contribute to the increase in the prevalence of chronic wounds. As a result, there is a greater demand for specialized wound care products, including topical wound agents, to manage these persistent wounds effectively. The prevalence and complexity of chronic wounds drive the demand for the segment.
The Gels segment is registering a CAGR of 8.7% during (2023 - 2030). The demand for gels in the market is fueled by their effectiveness in maintaining a moist wound environment, targeted delivery of active ingredients, application versatility, and their role in promoting wound healing across different wound types. The market continues to innovate and expand in gel formulations to meet the evolving wound care and management needs.
The North America region dominated the Global Topical Wound Agents Market by Region in 2022; thereby, achieving a market value of $956.3 million by 2030. The Europe region is anticipating a CAGR of 8% during (2023 - 2030). Additionally, The Asia Pacific region would exhibit a CAGR of 9.5% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/topical-wound-agents-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd., Molnlycke Health Care AB, Viatris, Inc. (Mylan N.V.), AstraZeneca PLC, Coloplast Group, Novartis AG, Pfizer Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), and ConvaTec Group PLC.
By End-use
By Application
By Product
By Geography
Companies Profiled
Unique Offerings 
